Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 4/20 | 0.44 |
| ▸ | MAOA | P21397 | 5/20 | 0.41 |
| ▸ | MAOB | P27338 | 5/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13100687 | 0.88 | ACHE (0.49) | TOP2AACHEMAOAMAOBKDM4C | |
| SCHEMBL17109975 | 0.88 | ADORA3 (0.51) | TOP2AACHEMAOAKDM4CADORA3 | |
| SCHEMBL27097179 | 0.87 | TOP2A (0.43) | TOP2AACHEMAOAMAOBADORA3 | |
| SCHEMBL280029 | 0.83 | TOP2A (0.50) | TOP2AACHEMAOAMAOBADORA3 | |
| SCHEMBL18354602 | 0.81 | TOP2A (0.42) | TOP2AACHEMAOAMAOBADORA3 | |
| SCHEMBL22907184 | 0.81 | TOP2A (0.42) | TOP2AACHEMAOAMAOBADORA3 | |
| SCHEMBL20129120 | 0.81 | TOP2A (0.42) | TOP2AACHEMAOAMAOBADORA3 | |
| SCHEMBL16942957 | 0.81 | TOP2A (0.42) | TOP2AACHEMAOAMAOBADORA3 | |
| SCHEMBL22906839 | 0.81 | ACHE (0.42) | TOP2AACHEMAOAMAOBKDM4C | |
| SCHEMBL793554 | 0.81 | GPR3 (0.46) | ACHEMAOAATMBCHEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10208026-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-02-19 | — | — | US | disclosed |
| US-20150266863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-24 | — | — | US | disclosed |
| US-20150266863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-24 | — | — | US | disclosed |
| US-20100256379-A1 | ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT | KAGOSHIMA UNIVERSITY | 2010-10-07 | — | — | US | disclosed |
| US-20100256379-A1 | ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT | KAGOSHIMA UNIVERSITY | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256379-A1 | ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT | H1-10, MAVS, HNRNPH3 | TOP2A 1390/4885ACHE 3302/4885MAOA 1548/4885 |
| US-10208026-B2 | Organic electroluminescent materials and devices | ZYX, LBR, LOXL1 | TOP2A 4528/4885ACHE 2145/4885MAOA 306/4885 |
| US-20150266863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ZYX, LBR, LOXL1 | TOP2A 4528/4885ACHE 2145/4885MAOA 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.